Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: Singapore Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20171
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Array Biopharma, now a wholly owned subsidiary of Pfizer1
Bayer1
Merck Sharp & Dohme LLC1
National Cancer Centre, Singapore1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms5
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Colorectal Neoplasms2
Ovarian Neoplasms2
Triple Negative Breast Neoplasms2
Appendiceal Neoplasms1
Bronchial Neoplasms1
Carcinoma, Pancreatic Ductal1
Cholangiocarcinoma1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.